Jove
Visualize
Contact Us

Related Experiment Videos

Hyperglycemia as a cardiovascular risk factor.

Steven J Haffner1, Holly Cassells

  • 1Department of Medicine, University of Texas Health Science Center at San Antonio, (SJH), San Antonio, Texas 78229-3900, USA.

The American Journal of Medicine
|December 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing Cervical Cancer and Human Papillomavirus Prevention Knowledge and HPV Vaccine Uptake through Mother/Daughter Education.

Journal of community health nursingยท2016
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Preventing type 2 diabetes is crucial for reducing cardiovascular disease risk. Strategies focusing on improved insulin sensitivity, like lifestyle changes and medication, can delay or prevent type 2 diabetes and its associated heart complications.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Type 2 diabetes mellitus significantly elevates coronary heart disease (CHD) risk and mortality.
  • Cardiovascular disease development is multifactorial, with hyperglycemia being one contributing factor.
  • Increased cardiovascular mortality risk exists even before the clinical onset of type 2 diabetes.

Purpose of the Study:

  • To highlight the importance of diabetes prevention for cardiovascular health.
  • To emphasize strategies targeting insulin sensitivity for type 2 diabetes prevention.
  • To explore interventions that reduce the incidence of type 2 diabetes.

Main Methods:

  • Review of epidemiologic data on A1c levels and complications.
  • Analysis of prediabetic states and insulin resistance patterns.

Related Experiment Videos

  • Examination of clinical trial data on diabetes prevention interventions.

    • Main Results:

    • A glycosylated hemoglobin (A1c) level below or equal to 7% is recommended for minimizing diabetes complications.
    • The prediabetic state shows an atherogenic pattern primarily in insulin-resistant individuals.
    • Lifestyle changes and medications (metformin, acarbose, troglitazone) effectively reduce type 2 diabetes incidence.

    Conclusions:

    • Preventing type 2 diabetes is a vital strategy for delaying or averting cardiovascular disease.
    • Interventions aimed at improving insulin sensitivity are key for diabetes prevention.
    • Early intervention in at-risk individuals can mitigate future cardiovascular events.